Help us: Donate
Follow us on:
×

Tag: Alex Zhavoronkov

May 08, 2020
Few things in aging research are ever straightforward, and today's topic is no exception, as two researchers enjoy some back and forth regarding whether and how the World Health Organization (WHO) should recognize the aging processes as a disease. Proposing a new framework to facilitate development of rejuvenation therapies Back in November 2019, an international...
April 22, 2020
In this 80-minute interview with Brent Nally, Dr. Alex Zhavoronkov of Insilico Medicine discusses the relationship between COVID-19 and age-related diseases, including how this 'gerophilic' disease primarily afflicts the elderly, how COVID-19 has affected research on aging, and many related topics, including how extending lifespan without extending healthspan puts our society at risk of hyperinflation...
January 29, 2020
The coronavirus epidemic is spreading from China into other countries, so here is what life extensionists should know about this situation and how they should handle it. A few months ago, we interviewed Dr. Jay S. Olshansky, a leading demographer from the School of Public Health at the University of Illinois at Chicago, whose areas...
December 05, 2019
A type of artificial intelligence technique is now being used to develop new drugs and therapies and could perhaps even help to solve aging. An urgent need for aging biomarkers There has long been an urgent need in our field to develop increasingly accurate biomarkers of aging so that the efficacy of interventions can be...
November 21, 2018
On January 29-31, 2019, the Longevity Therapeutics Summit is happening at the Argonaut Hotel in San Francisco, California. The conference is a great networking opportunity with some leading names in aging research giving talks during the event. This will be a two-day conference plus a pre-conference workshop hosted by our good friend Kelsey Moody from...